News
Parkinsons’ drug helps older people to make decisions
A drug widely used to treat Parkinson's Disease can help to reverse age-related impairments in decision making in some older people, a study from...
News
Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
New data presented at the 65th annual meeting of the American Academy of Neurology (AAN) show Gilenya® (fingolimod), the first oral disease modifying therapy...
News
New study highlights strong anti-cancer properties of soybeans
Soybean meal is a bi-product following oil extraction from soybean seeds. It is rich in protein, which usually makes up around 40% of the...
News
Studies for approval of new drugs have insufficient patients to evaluate safety
For medicines intended for chronic use, the number of patients studied before regulatory approval is insufficient to properly evaluate safety and long-term efficacy, requiring...
News
AstraZeneca to establish strategic R&D centres
AstraZeneca has announced plans to invest in strategic research and development centres in the UK, the US and Sweden to improve pipeline productivity and...
News
Merck announces collaboration with nordic Bioscience for Sprifermin
Merck today announced a strategic alliance with Nordic Bioscience Clinical Development A/S on Merck's investigational drug sprifermin (recombinant human FGF-18) in osteoarthritis (OA) of...
News
New monoclonal antibody developed that can target proteins inside cancer cells
Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.